Products You May Like
VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Firm”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an rising biotech firm, is happy to announce that it has appointed Mr. Henri Sant-Cassia, co-founder of The Acutely aware Fund, to its Board of Administrators.
Mr. Sant-Cassia has 10 years of expertise working within the plant medication subject and has been a serial entrepreneur since his early twenties. Since 2018, he has been a founding associate at The Acutely aware Fund, probably the most energetic enterprise fund within the psychedelic medication area. His experience consists of psychedelic compounds, working fashions, enterprise funding, progress and exit planning, in addition to managing media and investor relations campaigns. His work has created over $200 million in firm valuations throughout the psychedelic world, and he beforehand labored within the manufacturing, retail and analysis of cannabinoid-based merchandise. He holds a level in regulation from College Faculty London. Mr. Sant-Cassia additionally serves on the boards of Magic Med and Microdose, a media firm.
“I’m delighted to be working with Ahmad, who is among the new breeds of CEOs from the bioscience area, and Patrick, one of many longest serving members of the psychedelic medication group. We consider that BetterLife has huge untapped potential, each inside second era psychedelic therapies and within the wider medical subject,” commented Mr. Sant-Cassia.
“We’re extraordinarily happy to welcome Henri Sant-Cassia to our Board of Administrators. He brings a wealth of expertise within the psychedelic area, which will likely be very priceless as we execute our plans to develop non-hallucinogenic compounds to deal with melancholy and different psychological well being issues. We look ahead to working with The Acutely aware Fund staff and their intensive community throughout the psychedelic group,” commented Ahmad Doroudian, CEO of BetterLife.
BetterLife additionally broadcasts the resignation of Mr. Sergei Stetsenko from its Board of Administrators. The Firm thanks Mr. Stetsenko for his contributions to BetterLife.
About The Acutely aware Fund
The Acutely aware Fund is probably the most energetic early stage enterprise fund within the psychedelic medication area. It invests into drug discovery, clinics, dependancy packages, retreats, AI, telemedicine, media and coaching. Its international, platform-based method helps to remodel outcomes for sufferers with psychological well being, dependancy and power ache points.
The USD$60 million fund has backed 14 of the main firms within the sector, spanning drug discovery, clinics, dependancy, AI, and media, and has incubated 13 tasks, together with The Psychedelic Medication Affiliation, the primary psychedelic medication SPAC, and Microdose, a worthwhile media firm.
For additional data, please go to www.theconscious.fund.
About BetterLife Pharma Inc.
BetterLife Pharma Inc. is an rising biotechnology firm engaged within the improvement and commercialization of therapeutic prescribed drugs in addition to drug supply platform applied sciences. BetterLife is refining and growing drug candidates from a broad set of complementary interferon-based applied sciences which have the potential to interact the immune system to combat virus infections, such because the coronavirus illness (COVID-19) and human papillomavirus (HPV), and/or to instantly inhibit tumours to deal with particular sorts of most cancers.
For additional data please go to www.abetterlifepharma.com.
Contact Data:
Ahmad Doroudian, Chief Government Officer
Electronic mail: Ahmad.Doroudian@blifepharma.com
Telephone: 604-221-0595
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
No Securities Alternate has reviewed nor accepts duty for the adequacy or accuracy of the content material of this information launch. This information launch comprises forward-looking statements regarding product improvement, licensing, commercialization and regulatory compliance points and different statements that aren’t historic info. Ahead-looking statements are sometimes recognized by phrases equivalent to “will”, “could”, “ought to”, “anticipate”, “expects” and related expressions. All statements aside from statements of historic reality, included on this launch are forward-looking statements that contain dangers and uncertainties. There will be no assurance that such statements will show to be correct and precise outcomes and future occasions may differ materially from these anticipated in such statements. Essential elements that would trigger precise outcomes to vary materially from the Firm’s expectations embrace the failure to fulfill the situations of the related securities alternate(s) and different dangers detailed on occasion within the filings made by the Firm with securities rules. The reader is cautioned that assumptions used within the preparation of any forward-looking data could show to be incorrect. Occasions or circumstances could trigger precise outcomes to vary materially from these predicted, because of quite a few identified and unknown dangers, uncertainties, and different elements, lots of that are past the management of the Firm. The reader is cautioned to not place undue reliance on any forward-looking data. Such data, though thought of affordable by administration on the time of preparation, could show to be incorrect and precise outcomes could differ materially from these anticipated. Ahead-looking statements contained on this information launch are expressly certified by this cautionary assertion. The forward-looking statements contained on this information launch are made as of the date of this information launch and the Firm will replace or revise publicly any of the included forward-looking statements as expressly required by relevant regulation.
